-
Event
18 - 19 November 2026,
Save the date for the European Cancer Summit 2026 on 18 & 19 November, and EU-funded project events on 20 November - in Brussels & online!
In an era of political disruption and uncertainty, the European Cancer Summit 2025 convened the broad cancer community to chart a new path forward.
These extraordinary times call for extraordinary commitment. As budgets tighten and investments in health care come under intense scrutiny, the need to maximise every euro and drive innovation has never been greater. The cancer community must not only learn from past successes but also adapt rapidly to safeguard the future of patient care.
Unity is now more vital than ever, and nowhere is that unity better realised than at the biggest cancer policy event in Europe.
Read more
-
Event
17 - 18 February 2026, Cardo Brussels (& online)
Newly Implementable Programmes for Prostate, Lung and Gastric Cancer Screening
Three years ago, the European Union reshaped the agenda on cancer screening. The goal? Save lives through early detection, with a focus on prostate, lung, and gastric cancer.
How? Launch a series of projects – PRAISE-U, SOLACE, and TOGAS – to pilot and prepare for the implementation of new screening programmes which account for the needs of individuals and their different backgrounds. Now it's time to assess the progress and turn pilots into programmes.
This is a unique event for the cancer community. Make sure to be part of it.
17 & 18 February - Brussels & online
Registrations are open now!
Read more
-
news
25 November 2025
Warsaw, 24 November 2025 – The European Parliamentary Forum for Sexual and Reproductive Rights (EPF) together with the Institute for Patients‘ Rights and Health Education in Poland (IPPEZ) and the European Cancer Organisation (ECO) have launched the new edition of the HPV Prevention Policy Atlas 2025 at the Polish Senate during the event “HPV prevention in Poland and Europe”.
Read more
-
news
20 November 2025
Brussels, 20 November – Each year brings with it 58,000 new cases of cervical cancer in Europe and 27,000 deaths from the disease – all the result of the human papillomavirus (HPV).
It does not have to be this way.
Read more
-
Publication
November 2025
An estimated 31% of men and 25% of women in the EU will receive a cancer diagnosis before the age of 75. Quality screening programmes are essential to improve treatment outcomes and save lives.
Throughout 2024-2025, the European Cancer Organisation (ECO) worked alongside leading cancer experts and partner organisations to assess the current state of cancer screening across Europe.
Read more
-
news
19 November 2025
Major gaps in access, equity and implementation, findings show
Brussels, 18 November – An estimated 31% of men and 25% of women in the EU will receive a cancer diagnosis by age 75. Technological advances in cancer screening approaches offer new opportunities for early detection, but a new analysis shows that too many Europeans are not benefiting from well organised and accessible screening programmes.
Read more
-
Publication
November 2025
The European Cancer Organisation’s Research Policy Network, chaired by Professor Christine Chomienne, has published a new Green Paper on EU investment in cancer research.
Read more
-
Publication
November 2025
A new report from the European Cancer Organisation (ECO) and its HPV and Hep B Action Network highlights persistent inequalities in cervical cancer screening and HPV testing across Europe. It calls for stronger implementation of EU recommendations, greater coordination among European countries, and more cohesion in vaccination and screening programmes.
Read more
-
news
18 November 2025
Opportunities and Challenges
18 November, Brussels – Artificial intelligence (AI) is rapidly transforming virtually every aspect of cancer care – from prevention and diagnosis to treatment and survivorship. Europe can become a global leader in AI and cancer if the technology is properly harnessed. But a Wild West scenario must be avoided.
Read more
